Daily cardiology

ESC 2025: High-Dose Influenza Vaccine Effectiveness against Hospitalization in Older Adults 27.12.2025 5:20 ↓

High-Dose Influenza Vaccine Effectiveness against Hospitalization in Older Adults 📚 ESC 2025 Coverage: Double the Dose, Double the Defense? by Dr. Soleimani, Cardiovascular Specialist.

ESC 2025: B. Aminian, MD 27.12.2025 12:24 ↓

Early Discontinuation of Aspirin after PCI in Low-Risk Acute Myocardial Infarction (TARGET-FIRST)

Apixaban for Extended Treatment of Provoked Venous Thromboembolism (HI-PRO) 27.12.2025 4:59 ↓

Apixaban for Extended Treatment of Provoked Venous Thromboembolism (HI-PRO)

Impact 52: FINEARTS-HF: Modes of Death in HFmrEF & HFpEF 26.12.2025 5:51 ↓

Mode of Death in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The FINEARTS-HF RCT 📚 Impact 52: Finerenone and mode of death in HF: Where do we stand? A review by Dr. Soltani Moghadam, Cardiovascular Researcher.

Impact 51: Thrombolysis after recent DOAC intake 26.12.2025 3:43 ↓

📚 Impact 51: Intravenous thrombolysis in patients with ischemic stroke and recent ingestion of direct oral anticoagulants (DOACs), A review by Dr. Haeri, Neurologist.

H&H Academy in 7 minutes, Episode 7 26.12.2025 8:50 ↓

💊 Hypertension and Hyperlipidemia at your fingertips! 5️⃣ H&H Academy in 7 minutes, episode 7.

Impact 50: Thrombolysis before thrombectomy: A bridge not fallen 26.12.2025 5:18 ↓

📚 Impact 50: Thrombolysis before thrombectomy: A bridge not fallen, A review by Dr. Benam, Cardiovascular Specialist.

Case Discussion 125: DVT Prophylaxis in Post-Ischemic Stroke Patients 25.12.2025 6:06 ↓

🫀Case Discussion 125: DVT Prophylaxis in Post-Ischemic Stroke Patients, by Dr. Bikdeli, Cardiovascular specialist.

Impact 49: SGLT2 inhibitors in CKD: are they really effective in all patients? 24.12.2025 4:16 ↓

SGLT2 inhibitors in CKD: are they really effective in all patients?

Impact 48: DOACs for Rheumatic Heart Disease-Associated AF Post-Bioprosthetic MVR 23.12.2025 3:41 ↓

DOACs for Rheumatic Heart Disease-Associated AF Post-Bioprosthetic MVR

22nd ACC 2025 Congress Coverage: FLAVOUR II Trial 22.12.2025 3:04 ↓

22nd ACC 2025 Congress Coverage: FLAVOUR II Trial

Case Discussion 124: Anticoagulation in Patients with Mitral Stenosis 22.12.2025 5:27 ↓

Case Discussion 124: Anticoagulation in Patients with Mitral Stenosis

23rd ACC 2025 Congress Coverage: FAME 3 Trial 22.12.2025 1:26 ↓

23rd ACC 2025 Congress Coverage: FAME 3 Trial

21st ACC 2025 Congress Coverage: DapaTavi Trial 21.12.2025 1:54 ↓

🫀21st ACC.25 Congress Coverage: SGLT2 Inhibitors Progressing to New Standard After TAVI, DapaTAVI Trial, by Dr. Tahamtan, Fellowship of Electrophysiology. 🔸Stay tuned for more insights from the late-breaking trials presented during this magnificent scientific event.

19th ACC 2025 Congress Coverage: HPV Infection and Cardiovascular Disease 21.12.2025 3:29 ↓

19th ACC 2025 Congress Coverage: HPV Infection and Cardiovascular Disease

20th ACC 2025 Congress Coverage: ALLEPRE Trial 21.12.2025 2:13 ↓

🫀20th ACC.25 Congress Coverage: Alliance for secondary prevention after an acute coronary syndrome, ALLEPRE Trial, by Dr. Nasrollahizadeh, General Practitioner. 🔸Stay tuned for more insights from the late-breaking trials presented during this magnificent scientific event.

18th ACC 2025 Congress Coverage: SOUL Trial 21.12.2025 2:48 ↓

18th ACC 2025 Congress Coverage: SOUL Trial

L H&H Accademy in 7 Minutes, Ep 6, 50y M 19.12.2025 8:19 ↓

💊 Hypertension and Hyperlipidemia at your fingertips! 5️⃣ H&H Academy in 7 minutes, episode 6

5th ACC 2025 Congress Coverage: PURSUIT Trial 09.06.2025 2:17 ↓

5th ACC 2025: PURSUIT Trial

13th ACC 2025 Congress Coverage: EquiOx Study 09.06.2025 2:23 ↓

13th ACC 2025: EquiOx Study

11th ACC 2025 Congress Coverage: HOST-BR Trial 09.06.2025 2:23 ↓

11th ACC 2025: HOST-BR Trial

12th ACC 2025 Congress Coverage: RIVAWAR Trial 09.06.2025 2:12 ↓

12th ACC 2025: RIVAWAR Trial

6th ACC 2025 Congress Coverage: FRESH-UP Study 09.06.2025 2:12 ↓

6th ACC 2025: FRESH-UP Study

14th ACC 2025 Congress Coverage: SBP < 130 mmHg Linked to Reduced CV Mortality in Adults +80 Y 09.06.2025 2:12 ↓

14th ACC 2025: SBP &lt; 130 mmHg Linked to Reduced CV Mortality in Adults +80 Y

15th ACC 2025 Congress Coverage: DapaTAVI Trial 09.06.2025 1:51 ↓

15th ACC 2025: DapaTAVI Trial